Avantor, Inc. (AVTR) — Current Report

AI-Powered SEC Filing Analysis

← All AVTR filings

Want the newest filings?

This analysis covers the filing from 2026-04-29. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Earlier Current Report filings

Filed: 2026-04-01
  • Avantor's CFO, Mr. R. Brent Jones, has resigned to join a company outside the life sciences industry. This leadership change may introduce uncertainty in the near term.
  • The company has appointed Steven Eck, the current Senior Vice President and Chief Accounting Officer, as the interim CFO while it undertakes a search for a permanent replacement.
  • To compensate Mr. Eck for the additional responsibilities as interim CFO, the company has provided him with a monthly payment and a one-time restricted stock unit award, aligning his interests with shareholders.
Filed: 2026-02-11
  • Avantor, Inc. announced a realignment of its reportable business segments, consolidating into two new segments: VWR Distribution & Services and Bioscience & Medtech Products, effective in Q1 2026.
  • The company provided unaudited supplemental recast financial information for fiscal years 2023-2025 to assist investors in understanding the effects of the segment reporting changes on its historical results.
  • Avantor reported its Q4 2025 and full-year 2025 financial results, which will be discussed on a conference call with investors on February 11, 2026.

Other reports for Avantor, Inc.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.